KS is a glycosaminoglycan-like molecule present in living organisms. It is found primarily in the cornea, cartilage, bone, and some neural tissues and plays an important biological function. However, several diseases are associated with metabolic disorders or abnormal synthesis of KS. By developing KS inhibitors, it is possible to regulate its synthesis and degradation processes, thereby intervening in the development and progression of related diseases. CD BioGlyco specializes in providing diversified Glycosaminoglycan Inhibitor Development Services, including KS inhibitor development services, to meet the needs of a variety of different types of clients. The processes of our services are as follows:
Fig.1 Classification of KS inhibitors. (CD BioGlyco)
Fig.2 The range of KS chain structures. (Funderburgh, 2022)
CD BioGlyco is equipped with a team of experienced researchers. Our commitment is to deliver high-quality KS inhibitor development services that meet and exceed the expectations of our clients. For further information regarding our services, please feel free to contact us directly.